Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 1, 2002

Circulation. 2002
Published online before print July 1, 2002, doi: 10.1161/01.CIR.0000023945.21317.27
A more recent version of this article appeared on August 6, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/6/725    most recent
01.CIR.0000023945.21317.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apple, M.
Right arrow Articles by Bass, B. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Apple, M.
Right arrow Articles by Bass, B. G.
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Arterial thrombosis
Right arrow Catheter-based coronary and valvular interventions: other

Submitted on March 8, 2002
Revised on May 8, 2002
Accepted on May 8, 2002

Radioactive 133-Xenon Gas-Filled Balloon to Prevent Restenosis. Dosimetry, Efficacy, and Safety Considerations

Marc Apple MD, Ron Waksman MD*, Rosanna C. Chan PhD, Yoram Vodovotz PhD, Jana Fournadjiev PhD, and Bill G. Bass PhD

From Parkview Radiation Oncology Center (M.A.), Fort Wayne, Ind, and Cardiovascular Research Institute, Division of Cardiology, Washington Hospital Center, Washington, DC.

* To whom correspondence should be addressed. E-mail: ron.waksman{at}medstar.net.

Background—Ionizing radiation administered intraluminally via catheter-based systems using solid ß and {gamma} sources or liquid-filled balloons has shown reduction in the neointima formation after injury in the porcine model. We propose a novel system that uses a 133-Xenon (133Xe) radioactive gas-filled balloon catheter system.

Methods and Results—Overstretch balloon injury was performed in the coronary arteries of 33 domestic pigs. A novel 133Xe radioactive gas--filled balloon (3.5/45 mm) was positioned to overlap the injured segment with margins. After vacuum was obtained in the balloon catheter, {approx}2.5 cc of 133Xe gas was injected to fill the balloon. Doses of 0, 7.5, 15, and 30 Gy were delivered to a distance of 0.25 mm from the balloon surface. The dwell time ranged from 1.0 to 4.0 minutes, depending on the dose. Localization of 133Xe in the balloon was verified by a {gamma} camera. The average activity in a 3.5/45-mm balloon was measured at 67.7±12.1 mCi, and the total diffusion loss of the injected dose was 0.26% per minute of the injected dose. Bedside radiation exposure measured between 2 and 6 mR/h, and the shallow dose equivalent was calculated as 0.037 mrem per treatment. Histomorphometric analysis at 2 weeks showed inhibition of the intimal area (intimal area corrected for medial fracture length [IA/FL]) in the irradiated segments of 0.26±0.08 with 30 Gy, 0.07±0.24 with 15 Gy, and 0.12±0.89 with 7.5 Gy versus 0.76±0.08 with control P<0.001.

Conclusions133Xe gas--filled balloon is feasible and effective in the reduction of neointima formation in the porcine model and safe for use in coronary arteries.


Key words: restenosis • balloon • catheters